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ABSTRACT
￿
Kidneys were perfused with [seS]sulfate for 4 h in vitro to radiolabel sulfated proteoglycans.
Glomeruli were isolated from the labeled kidneys, and purified fractions of glomerular basement
membrane (G BM) were prepared therefrom . Proteoglycans were extracted from G BM fractions by use
of 4 M guanidine-HCI at 4°C in the presence of protease inhibitors. The efficiency of extraction was
-55% based on 35S radioactivity. The extracted proteoglycans were characterized by gel-filtration
chromatography (before and after degradative treatments) and by their behavior in dissociative CsCl
gradients. A single peak of proteoglycans with an Mr of 130,000 (based on cartilage proteoglycan
standards) was obtained on Sepharose CL-4B or CL-6B. Approximately 85% of the total proteoglycans
were susceptible to nitrous acid oxidation (which degrades heparan sulfates), and -15% were
susceptible to digestion with chondroitinase ABC (degrades chondroitin-4 and -6 sulfates and
dermatan sulfate) . The released glycosaminoglycan (GAG) chains had an M r of
￿
26,000. Density
gradient centrifugation resulted in the partial separation of the extracted proteoglycans into two types
with different densities: a heparan sulfate proteoglycan that was enriched in the heavier fraction (p
> 1.43 g/ml), and a chondroitin sulfate proteoglycan that was concentrated in the lighter fractions
(p < 1 .41) . The results indicate that two types of proteoglycans are synthesized and incorporated into
the GBM that are similar in size and consist of four to five GAG chains (based on cartilage proteoglycan
standards). The chromatographic behavior of the extracted proteoglycans and the derived GAG,
together with the fact that the two types of proteoglycans can be partially separated in the density
gradient, suggest that the heparan sulfate and chondroitin sulfate(s) are located on different core
proteins.
Latticelike networks of anionic sites have recently been de-
tected in the laminae rara interna and externa ofthe glomerular
basement membrane (GBM) (1, 15) (see Fig. 1). Based on
cytochemical (16) and biochemical (17, 24) data, these sites
have been shown to consist in large part of heparan sulfate, a
sulfated glycosaminoglycan (GAG). Evidence has also been
obtained indicating that GAGs play an important functional
role in maintaining the charge selective permeability properties
of the GBM to molecules, because their enzymatic removal
was shown to result in increased permeability of the GBM to
native ferritin (18) and to l25í-labeled bovine serum albumin
(20).
Up to now, our attention has been focused on establishing
the nature and function of the GAGS present in the GBM.
However, we assumed from the outset that the GAG chains
were present as protein-polysaccharide complexes or proteo-
glycans covalently bound (by O-glycosidic linkages) to protein,
because normally (with the possible exception of hyaluronic
acid) GAGs do not exist free in the extracellular matrix (3, 25).
Furthermore, that the sites bore a striking resemblance (after
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staining with ruthenium red) to proteoglycan granules in other
locations (12) and are sensitive to proteolytic digestion (16)
suggested their proteoglycan nature.
In this study we set out to extract and to partially characterize
the heparan sulfate proteoglycan from purified GBM, using
established techniques for the isolation of proteoglycans (9).
Because the amount of GAG present in the GBM is small
(<I% of its dry weight [17]), we labeled the proteoglycans with
['S]sulfate in a kidney perfusion system to facilitate their
isolation and characterization by monitoringradioactivity. The
results, which were briefly presented elsewhere (19), demon-
strate that two types of newly synthesized proteoglycans can
be recovered from purified GBM: heparan sulfate proteogly-
can, which is the predominant type (-85%), and a chondroitin
sulfate proteoglycan (-15%).
MATERIALS AND METHODS
Materials
Male, Charles River CDR rats weighing 240-300 g were used in these experi-
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Diagrammatic representation of anionic sites in the lam-
ina Tara interna and externa of theGBM based on results of labeling
with cationic probes . The sites are visualized as angular particles
(-20 nm) with fine filaments ("3 nm) extending from their points
to connect one particle with another, with the membranes of
adjoining endothelial and epithelial cells, and with the lamina
densa .
ments . Chondroitinase-ABC was purchased from Miles Laboratories, Inc ., Elk-
hart, Ind . ; papain (twice crystallized) from Sigma Chemical Co., St. Louis, Mo .;
the Zwitterionic detergent, Zwittergent 3-12 from Calbiochem-Behring Corp .,
American Hoechst Corp., San Diego, Calif ; ['H] serine (2.75 Ci/mmol) and
["S]sulfate (100 Ci/mmol) from NewEngland Nuclear, Boston, Mass . Sepharose
and Sephadex were obtained from Pharmacia Inc., Piscataway, N . J . andHydro-
fluor scintillation fluid from National Diagnostics, Inc., Advanced Applications
Institute Inc., Parsippany, N. J . ['H]Serine-labeled cartilage proteoglycan mon-
omer (21) was a gift ofDr. James Kimura, National Institute ofDental Research,
National Institutes of Health, Bethesda, Md .
Column Chromatography
Columns of Sepharose CL-4B and CL-6B (110 x0.9 cm) were eluted with 4
Mguanidine-HCI, 100mM Tris-HCl, 0.1Msodium sulfate, 0.5% (vol/vol) Triton
X-100, pH 7.0. Their flow rates were -2 .0 ml/h, and effluent fractions of 0.5 ml
were collected. The void (Vo) and total (V,) volumes of the columns, were
determined by eluting ['H]serine-labeled cartilage monomer (for Vo) and ['H]-
serine (forV,) . PD-10, Sephadex G-25 columns were eluted with the same buffer,
and 0.25-ml fractions were collected (21).
Radioisotope Analysis
Each effluent fraction (0.25 or 0.5 ml) in 4Mguanidine-HCIwasdiluted with
0.7 ml of 70% ethanol, and 12.5 ml of Hydrofluor were added. Samples were
counted in aBeckmanLS 355 scintillation counter (Beckman Instruments, Inc.) .
The spillover in samples with both 'H and'S activities was corrected by using
an external standard .
Kidney Perfusion
Animals were anesthetized with pentobarbital, the right kidney was isolated,
and the renal artery was cannulated and flushed with Krebs-Ringer bicarbonate
(KRB) . The cannulated kidney was removed from the animal, and kidney
perfusion was carried out in a recirculating perfusion system as described by
DeMello and Maack (7). The main modification involved perfusion of kidneys
at a relatively lower flow rate (12-15 ml/min, instead of 38-40 ml/min) . The
perfusate consisted of modified KRB containing [mS]sulfate (100 pCi/ml) . The
final inorganic sulfate concentration of the perfusate was adjusted to 50 WM (5 .8
fig/ml) .The kidneys were labeled for up to 4-5hundernormothermic conditions.
The incorporation ofthe precursor ['SS]sulfate was linear up to 4 h, so this time-
point was chosen to achieve maximal labeling of proteoglycans. After4 h, the
kidneys were perfused for an additional 30 min with a chasemedium containing
-5 mM inorganic sulfate. Tissue samples were taken and processed for electron
microscopy. The remaining portions of the labeled kidneys were then immersed
in 0.15M NaCl, rapidly frozen, and kept at -20'C overnight.
Isolation of Glomeruli and
Basement Membranes
Kidneys were thawed to4'C and glomeruli were isolated andGBM prepared
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therefrom by detergent treatment as previously described (15) . Asmall fraction
of the labeled GBM was processed for autoradiography; the remaining GBMs
(from 18 rat kidneys) were pooled . 1-ml aliquots (two or three per kidney) ofa
GBM suspension were prepared and kept at -20'C until further use .
Extraction of [ 35S]Sulfate-labeled Proteoglycans
from theGBM
Each frozen aliquot of GBM was thawed to 4°C, and proteoglycans were
extracted with 1 ml of 4M guanidine-HCI containing 0.01 M sodium EDTA,
0.01M sodium acetate, pH 5.8,0.1 M 6-aminohexanoic acid, 0.005 Mbenzami-
dine-HCl and 0.001M phenylmethylsulfonyl fluoride (28) . The extraction was
carried out for 24 h at 4°C with stirring. The unextracted residue was pelleted by
centrifugation at 10,000 rpm in a Beckman Microfuge (Beckman Instruments,
Inc., Spinco Div., Palo Alto, Calif.) and saved for further processing. A small
aliquot of the supernate was used for monitoring the radioactivity and for
calculating total counts per minute in the extract . The remaining supernate
containing the extracted proteoglycans was stored frozen until further analysis.
Fractionation and Characterization of the
Extracted Proteoglycans
The extracts were thawed (to 4°C) and chromatographed on PD-10 columns
(to remove free sulfate) . Aliquots (0.5 ml) ofthe material that eluted in the void
volume (>95% of the total counts) were then chromatographed on Sepharose
CL-4B and CL-6B as described above ; effluent fractions were monitored for
radioactivity . Approximately 85% of the radioactivity applied to these columns
was recovered in the effluent fractions . Other aliquots of the extracts were
extensively dialyzed against distilled water, lyophilized to dryness, and divided
into two portions. One portion was digested with chondroitinase-ABC (0 .25 U/
ml) in 0.1 M Tris-HCI buffer for 2 h at 37°C (30), while the other was treated
with nitrous acid(prepared by mixing equal volumes at20% (wt/vol) butyl nitrite
and I NHCI) for 4h at room temperature (2) . Both the enzyme-digested samples
and the nitrous acid-treated samples were relyophilized to dryness . They were
then reconstituted with 0.5 ml of 4M guanidine-HCI, mixed with Vo and V,
markers and chromatographed on Sepharose CL-6B and CL-4B . In separate
experiments, aliquots ofthe GBMextract were successively digested with chon-
droitinase-ABC followed by nitrous acid treatment before chromatography. The
molecular weight ofthe GBM proteoglycans was estimated by interpolation of
K,, values for peak elution positions with the data obtained from tryptic-chy-
motryptic digests of cartilage proteoglycan (14) .
Characterization ofGBM Proteoglycans in
Dissociative CsCl Density Gradient
TheGBM extracts were adjusted to an initial density of 1.42g/ml by addition
of0.45 g ofCsCl/g solution, centrifuged at 33,000 rpm in aSW 50.1 rotor for 72
h at 10°C (10), and fractionated into five approximately equal fractions, D, to
Ds, from bottom to top . The density of each fraction was determined with a
Bausch& Lomb Abb6-3L refractometer (Bausch& Lomb Inc., Scientific Optical
Products Div., Rochester, N . Y .). Aliquots of each of the fractions were chro-
matographed on Sepharose CL-4B before and after treatments with chondroiti-
nase-ABC or nitrous acid, as described above .
Characterization ofGBM GAGS
GAGS were obtained from two sources : (a) either directly from the GBMs
labeled with ['SS]sulfate ; or (b) from 4Mguanidine-HCI extracts oftheGBM . In
the latter case, aliquots were extensively dialyzed against distilled water and
lyophilized. GAG chains were released from both sources either by treatment
with 0.5 N NaOH at 45'C for l h (28) or by digestion with papain (I mg/ml) in
0.1 M sodium acetate buffer,pH 5.5, 5 mM cysteine, and 5 mM sodium EDTA
for6h at60 oC (17) . Subsequently, both the papain- and alkaline-treated samples
were extensively dialyzed against distilled water, lyophilized, and chromato-
graphed before and after treatment with chondroitinase-ABC or nitrous acid, on
Sepharose CL-6B . The molecular weights of the chains were estimated by
comparison of the peak elution positions with the values obtained by Wasteson
for chondroitin sulfate (33) .
Characterization of Unextracted GAG
Remaining in the GBM
The unextracted residue (remaining after guanidine extraction) was hydro-
lyzed with 0.5N NaOH at 50°Covernight (to releaseGAG),andthe total countsreleased were determined. Aliquots of the hydrolysate were extensively dialyzed
against distilled water and lyophilized to dryness. The dried residue was recon-
stituted as described above and then chromatographed on PD-10 and Sepharose
CL-6B, before and after treatment with chondroitinase-ABC or nitrous acid.
RESULTS
Preservation of Glomeruli and of the
Labeled GBMs
The overall architecture of the glomeruli was well preserved.
The basement membranes prepared by the detergent method
consists of intact loops of GBM (see Fig. 19 of reference 15).
Autoradiography (not shown) revealed numerous silver grains
associated with them. The efficiency of labeling of the GBM
with ["S]sulfate in the organ perfusion system was -100-fold
that observed in vivo (24). The rate of incorporation of the
precursor into proteoglycans extracted from the GBM was
linear up to 4 h; at this time point an average of 40,000 cpm
were present in the GBM fraction prepared from each kidney
of a mature rat weighing 250-300 g (Table I).
Extraction of Newly Synthesized Proteoglycans
from the GBM
Initially, several different procedures were tested for extrac-
tion ofthe proteoglycans from the GBM. Maximum efficiency
of 55% was achieved when GBM were extracted with 4 M
guanidine-HCI (Table 1). The presence of Zwitterionic deter-
gent in combination with guanidine-HCI did not improve the
efficiency ofextraction, although this procedure has proved to
be effective for extracting proteoglycans from chondrocytes
(22). More than 95% of the radioactivity in the 4 M guanidine-
HCI extract was recovered in the void volume of a PD-10
column, indicating that the radioactivity was present in the
newly synthesized, macromolecular components of the GBM.
Chromatographic Analyses of the
Extracted Proteoglycans
When the proteoglycans (extracted with 4 M guanidine-HCI)
were chromatographed on Sepharose CL-4B or CL-6B, they
eluted as a single peak of radioactivity with Ka values of 0.45
and 0.23, respectively (Fig. 2A and B). When the extracted
proteoglycans were subjected to nitrous acid oxidation, a pro-
cedure that selectively degrades N-sulfated GAGs (heparan
sulfates) (2), -88% of the radioactivity was released from the
proteoglycan peak into the totalcolumn volume, whereas when
the extracted proteoglycans were digested with chondroitinase
ABS (which specifically degrades chondroitins 4- and 6-sulfate
and dermatan sulfate), before chromatography, 12-15% of the
radioactivity was released (Fig. 3). In both cases, the elution
position of the resistant fractions (peaks C and B, respectively,
in Fig. 3) was unchanged. Successive treatments with chondro-
itinase-ABC and nitrous acid resulted in release of 100% of the
radioactivity from the extracted proteoglycans. These results
demonstrate that the majority of the proteoglycan macromol-
ecules are sensitive to nitrous acid and resistant to chondroiti-
nase-ABC treatment, indicating that they contain heparan
sulfate. A minority of the proteoglycan molecules are resistant
to nitrous acid and sensitive to digestion with chondroitinase
ABC, indicating that they contain chondroitin-4 or -6 sulfate
or dermatan sulfate. Based on their similar elution profiles,
both populations of proteoglycans appear to have virtually the
same size distribution.
Efficiency of Extraction of [ 35S]Sulfate-labeled Proteoglycan
from the GBM * (Data Are Given per Kidney)
Extraction procedure
TABLE I
* Radiolabeled basement membranes were extracted, and the residue subse-
quently was hydrolyzed in alkali; both the extract and the hydrolysate were
chromatographed on PD-10 Sephadex G-25 columns where >95% of the
radioactivity in each case was recovered in the Vo fraction. Total counts in
the GBM preparation from one kidney varied between 30,000-47,000 cpm.
*Alkaline treatment (0.5 N NaCH) at 50*C for 12 h.
Behavior in Dissociative CsCl Gradients
When the extracted proteoglycans were fractionated in a
dissociative CsCI density gradient, a partial separation of the
two types of proteoglycans was achieved (Table II). Although
the separation was incomplete, the ntirous acid-sensitive pro-
teoglycans were concentrated in the fractions of higher density
(i.e., Dt and Dz with p > 1 .43 g/ml), whereas the chondroiti-
nase-sensitive proteoglycans were concentrated in the D4 and
D5 fractions at bouyant densities < 1 .41 g/ml. When aliquots
of the gradient fractions were chromatographed on Sepharose
CL-4B in each case there was a single peak with a minor
increase in the K.,, values between Dt (Ke = 0.44) and D5 (Ke
= 0.49). This indicates that the proteoglycans in the bottom
fractions were slightly larger than those in the top fractions.
Characterization of GAGS of the GBM
When alkaline hydrolysates of whole GBMs or of the 4 M
guanidine-HCI extracts were chromatographed on Sepharose
CL-6B, there was a shift in the elution profiles of the released
GAG chains as compared with those ofthe intact proteoglycans
(Fig. 4). The Ka increased from 0.23 (for the intact proteogly-
can) to 0.44 (for the GAG chains). Treatment of GAGs with
nitrous acid or chondroitinase-ABC before chromatography
resulted in the release of -85 and -15%, respectively, of the
radioactivity into the total column volume. In either case there
was no detectable change in the elution profile of the resistant
GAG peak (Fig. 5, profiles B and C).
The GAG fractions obtained after papain digestion (before
or after degradative treatments) had profiles nearly identical to
those obtained for GAGs recovered after alkaline hydrolysis.
GAGs in the Unextracted GBM Residue
The GAG fractions released by alkaline hydrolysis from the
unextracted GBM residue were very similar to those released
from the extracted proteoglycans in (a) theirelution profile on
Sepharose CL-6B and (b) in the fact that ^-85% of the GAG
fraction was sensitive to nitrous acid, whereas ^-15% was
sensitive to chondroitinase-ABC (data not shown). This indi-
cates that the GAG composition of the unextracted proteogly-
cans is similar to that of the extracted proteoglycans.
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4 M GuCl for 24 h at 4°C 25,400 20,760 55
4% Zwittergent for 24 h at 4°C 4,120 39,170 10
4% Zwittergent for 12 h followed by 25,740 20,890 55
4 M GuCl for another 12 h at 4°C
4% Zwittergent plus 4 M GuCl for 24 24,310 20,840 54
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FIGURE 2
￿
Sepharose CL-4B (A) and CL-6B (B) chromatograms of
aliquots of a 4 M guanidine-HCI extract of GBM. Arrows indicate
wherethe 3H-labeled molecularweight standards (cartilage proteo-
glycan monomer [Vol and serine [V,]) that were included in each
runelute. An approximate molecularweight of 130,000 forthe intact
proteoglycan is estimated by interpolating the Ke values for peak
elution positions with thedata obtained from the enzymaticdigests
of cartilage proteoglycan (14).
Theresults ofthis investigation demonstrate that proteoglycans
are synthesized and incorporated into the GBM during perfu-
sion of rat kidneys in vitro. Two types of newly synthesized,
sulfated proteoglycans were extracted from GBM fractions: a
nitrous acid-sensitive heparan sulfate proteoglycan (HS-PG)
and a chondroitinase-ABC-sensitive, chondroitin sulfate pro-
teoglycan (CS-PG). Themajorcomponentwasheparansulfate
proteoglycan, which made up ^-85% of the total. It should be
noted that the relative amounts of the heparan sulfate and
chondroitin sulfate proteoglycans synthesized andincorporated
into the GBM in vitro is identical to that of radiolabeled
heparan sulfate andchondroitin sulfate foundto be synthesized
and incorporated into the GBM in vivo (24).
The size ofthetwo types of proteoglycans (asdetermined by
the elution profiles on Sepharose CL-6B) appear similar and is
equivalent to that of a chondroitin sulfate-peptide fraction
(tryptic digest) isolated from cartilage (14) with an average Mr
of 130,000, containing four or five GAG chains. However, the
two proteoglycans could be partially separated by virtue of
their behavior in a dissociative CsCl gradient, where the HS-
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FIGURE 3 Sepharose CL-48 chromatograms of newly synthesized
proteoglycan either intact (A) or after treatment with chondroiti-
nase-ABC (B) or nitrous acid (C). Treatments with chondroitinase-
ABC and nitrous acid released -12% and-88% of the radioactivities,
respectively, to the total column volume.
TABLE II
Distribution of NewlySynthesized Radiolabeled Intact
Proteoglycans in a Dissociative CsCl Gradient'
' Glomerular basement membranes from one
15S_labeled kidney were ex-
tracted with 4 M guanidine-HCI, and the extract was fractionated by
centrifugation on a CsCI gradient under conditions described in the Mate-
rials and Methods. Five fractions (D,-Ds) were collected and subjected
successively to digestion with chondroitinase-ABC to identify chondroitin
sulfate proteoglycans (CS-PG) and nitrous acid oxidation to identify heparan
sulfate proteoglycans (HS-PG) .
PG was enriched in theheavier fraction (p > 1.43) andthe CS-
PG was concentrated in the lighter fraction (p < 1.41). In
general, proteoglycans with higher buoyant densities have a
higher ratio of GAG to protein (9); however, the degree of
sulfation can also influence the density. Even though the
separation of the two proteoglycans is incomplete in the gra-
dient, the results strongly suggest that the two types of GAG
are present on two different core proteins. Moreover, the fact
that after nitrous acid or chondroitinase-ABC treatment of the
proteoglycansthe elution positions ofthe resistant fractionsdo
not change, renders it unlikely that there is any appreciable
portion of the proteoglycans that contains both chondroitin
sulfate and heparan sulfate chains.
Regarding the location of the twotypesofproteoglycans, we
have previously presented cytochemical evidence based on
Fraction Density
Total
cpm
% Total
cpm
HS- PG
% Total
cpm
CS-PG
Ke (Seph-
arose CL-
4B)
g/ml %
D, 1.47 30 30 0 0.44
D2 1.44 21 20 1 0.45
D3 1.42 16 14 2 0.46
De 1.41 15 11 4 0.48
De 1.39 18 10 8 0.49FRACTION
FIGURE 4
￿
Sepharose CL-68 chromatograms of intact proteoglycan
(solid line) and of GAG chains released after alkaline treatment
(dashed line). With alkaline treatment, the Ke increased from 0.23
(130,000 mol wt) to 0.44 (-26,000 mol wt), indicating that the
newly synthesized proteoglycan has four to five GAG chains at-
tached to its core protein.
specific enzyme removalthat theheparan sulfate proteoglycans
are concentrated in the laminae rarae (intema and extema) of
the GBM (16), where they are most likely the products of the
overlying endothelium and epithelium, respectively. In addi-
tion, they are also found in the mesangial matrix. No direct
information is available on the location in the glomerulus or
the cell source of the chondroitin sulfate proteoglycans; how-
ever, Striker et al. (31) have recently analyzed GAG synthe-
sized by glomerular cell lines in culture, and have shown that
cultured epithelial cells synthesize predominantlyheparan sul-
fates, whereas mesangial cells synthesize predominantly chon-
droitin sulfates.Thesefindings raisethepossibility that the CS-
PG may be the product of the mesangial cells.
It is clear from the present results as well as our previous
studies on the GAG composition of the rat (17, 24) and dog
(26) GBMthat theHS-PG is themain proteoglycan component
of the GBM. We have also established that the presence of
these GAG (aswell as chondroitin sulfates) is required forthe
GBM to carry out its normal filtration function (18, 20).
Accordingly, the properties of these molecules and their con-
stituent polysaccharide moieties have great inherent interest.
Based on our results it appears that each heparan sulfate
monomer contains several GAG chains, because the intact
heparan sulfate proteoglycan elutes on thecolumn much earlier
(Ke = 0.23) than the released GAG. We have noted above
that theelution profile of the HS-PG (aswell as the CS-PG) is
similar to that of a chondroitin sulfate-peptide fraction (Mr =
130,000) that contains four of five GAG chains (each with an
average Mr of 26,000) obtained from cartilage. Thus, the HS-
PG isolated from the GBM differs from those isolated from
other sources. To date heparan sulfate proteoglycanshave been
isolated from only a few sources-notably hepatocyte (29) (or
hepatoma [27]) cell membranes or the basement membrane-
like matrix secreted by a mouse tumor (EHS sarcoma) (11).
The former is much smaller (75,000) and has smaller GAG
chains (- 14,000), whereas the latter has a much larger Mr
(750,000) and larger GAG chains (70,000).
Up until recently, heparan sulfate and heparan sulfate pro-
15
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FIGURE 5
￿
Sepharose CL-6B chromatograms of GAGS obtained after
alkaline hydrolysis of proteoglycans and eluted either directly (A),
or after chondroitinase-ABC digestion (B), or after nitrous acid
treatment (C). Treatments with chondroitinase-ABC and nitrous
acid released "-15 and -85% of the radioactivities, respectively, to
the total column volume. Note that the proportion of radioactivities
released by these treatments is similar to that released from intact
proteoglycans by the same treatments (Fig. 3).
teoglycans were believed to be associated primarily with cell
surfaces (3, 25) where they are known to interact with fibro-
nectin and other cell surface components (6, 34). Our studies
have demonstrated that heparan sulfate proteoglycans are
widely distributed among renal basement membranes, because
we have found ruthenium red-stained proteoglycan granules
that aresensitive to digestion with heparitinase associated with
the basement membranes of the renal tubule epithelium, the
vascular endothelium of the peritubular capillaries, and Bow-
man's capsule (16). Earlier, regular networks of proteoglycan
granules had been seen after staining with ruthenium red in
association with embryonic basement membranes (13, 32) and
those of mouse mammary epithelium (8). Thus, proteoglycans
arewidely distributed amongbasement membranesin avariety
of locations and may represent a general component of base-
ment membranes.
Our results indicate that -55% of the total proteoglycans
synthesized by the perfused kidney and incorporated into the
GBM over a 4-h incubation period in vitro can be extracted by
the dissociative solvent, 4 M guanidine-HCI, whereas ^-45%
cannot. It is of interest that the GAGchains released from the
extracted proteoglycans and those released from the insoluble
residue are indistinguishable in their chromatographic behav-
iorandcomposition. It can be assumedthat the former proteo-
glycan fraction is noncovalently, but firmly, associated with
the GBM. Although theproteoglycans remainingin the residue
appear to be the same or very similar to those solubilized, they
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53 1have formed a tighter, possibly covalent, interaction with other
components of the GBM. Whether the soluble and insoluble
proteoglycans represent different compartments or whether,
with time, more of the extractable proteoglycans become in-
soluble remains to be determined. Indeed the interactions by
which these proteoglycans associate with other components of
the GBM, such as basement membrane collagen or laminin or
fibronectin, are not known at present. They may involve inter-
actions via either the polypeptide or GAG portions of the
proteoglycans or most likely both. It is of interest to note that
our immunocytochemical studies (4, 5) indicate that the attach-
ment proteins fibronectin and laminin, like the HS-PG, are
both concentrated in the laminae rarae, whereas type IV col-
lagen is concentrated in the lamina densa. Recent studies on
heparan sulfate proteoglycans from hepatocytes (23) and cells
in culture (6) indicate that heparan sulfate interacts with pol-
ysaccharide receptors on the cell surfaces, and also indicates
that at least some of the HS-PG molecules interact with the
cell membrane through hydrophobic portions of their core
protein (23).
Based on their properties, a few possible functions have been
suggested for the HS-PG and the CS-PG present in the GBM,
of which the most important is their role in glomerular perme-
ability (18, 20). Under normal conditions the GBM is highly
negatively charged, which is important for retaining (by elec-
trostatic repulsion) anionic plasma proteins in the circulation.
Direct evidence for a role of GAG in GBM permeability was
obtained by demonstrating that enzymatic removal of GAG
results in an increased permeation of anionic proteins (ferritin
[18] and albumin [20]) into the GBM, and leakage of these
tracers into the urinary spaces.
In summary, we have isolated proteoglycans from purified
GBM fractions and have partially characterized the proteogly-
cans synthesized and incorporated into the GBM in vitro. We
have shown that there are two types ofproteoglycans present-
a heparan sulfate proteoglycan and a chondroitin sulfate pro-
teoglycan-and we have obtained evidence that the two types
of GAG are present on two different core proteins. Further
work is needed to clarify the nature of the interaction of the
proteoglycans with other GBM components and with the sur-
face components of glomerular cells.
This work was supported by research grant AM 17724 (to M. G.
Farquhar) from the National Institutes of Health.
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